Leiden University Medical Center
Clinical trials sponsored by Leiden University Medical Center, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain scans reveal hidden vascular clues in early Alzheimer's Results expected Sep 2026 (estimated)
- Can the dirt under our feet shape the bacteria in our gut? Results expected Sep 2026 (estimated)
- Your genes could guide safer drug doses Results expected Sep 2026 (estimated)
- Can a toolkit help family doctors catch heart risk sooner? Results expected Oct 2026 (estimated)
- Brain aneurysm survivors may have hidden belly danger – simple ultrasound could save lives Results expected Dec 2026 (estimated)
-
Can a better antidote stop opioid overdoses faster?
Disease control Stopped earlyThis study investigates how effectively two opioid antidotes—naloxone (given as a nasal spray or injection) and nalmefene (given as an injection)—can reverse dangerous breathing problems caused by strong opioids like fentanyl. The trial includes both healthy volunteers and people…
Phase 1 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Scientists probe mysterious loss of nose immune cells in aging
Knowledge-focused Stopped earlyThis observational study aims to understand why older adults lose certain immune cells (T cells) from their nasal passages, which may make them more prone to respiratory infections. Researchers will compare young adults (18-30), healthy older adults (65+), and frail older adults …
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New test may expand olaparib benefits to more ovarian cancer patients
Knowledge-focused Stopped earlyThis study tested a new lab method (RAD51 assay) to see if it could identify ovarian cancer patients whose tumors are vulnerable to the drug olaparib, even if they don't have BRCA gene mutations. The goal was to find a larger group of patients who might benefit from this treatmen…
Phase 2 • Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC